De Luca Daniele, Dell'Orto Valentina
Division of Paediatrics and Neonatal Critical Care, APHP, South Paris University Hospitals, Medical Centre "A.Béclère", Paris, France.
Institute of Anaesthesiology and Critical Care, Catholic University of the Sacred Heart, Rome, Italy.
Arch Dis Child Fetal Neonatal Ed. 2016 Nov;101(6):F565-F570. doi: 10.1136/archdischild-2016-310664. Epub 2016 Jun 28.
Non-invasive high-frequency oscillatory ventilation (NHFOV) consists of the application of a bias flow generating a continuous distending positive pressure with superimposed oscillations, which have constant frequency and active expiratory phase. NHFOV matches together the advantages of high-frequency ventilation (no need for synchronisation, high efficacy in removing CO) and nasal continuous positive airway pressure (CPAP) (non-invasive interface, increase in functional residual capacity allowing oxygenation to improve). There is enough clinical expertise demonstrating that NHFOV may be tried in some selected cases, in whom CPAP or conventional non-invasive ventilation have failed. Nonetheless, there are no clear data about its clinical usefulness and there is a need for randomised controlled studies. Our purpose is to review the physiology and biological effects of NHFOV, to present the current clinical evidence on its use, to provide some guiding principles to clinicians and suggest directions for further research.
无创高频振荡通气(NHFOV)包括应用偏流,产生持续扩张性正压并叠加振荡,这些振荡具有恒定频率和主动呼气阶段。NHFOV结合了高频通气(无需同步、清除二氧化碳效率高)和经鼻持续气道正压通气(CPAP)(无创接口、增加功能残气量从而改善氧合)的优点。有足够的临床专业知识表明,在某些CPAP或传统无创通气失败的特定病例中,可以尝试使用NHFOV。然而,关于其临床实用性尚无明确数据,需要进行随机对照研究。我们的目的是回顾NHFOV的生理学和生物学效应,介绍其使用的当前临床证据,为临床医生提供一些指导原则,并提出进一步研究的方向。